BTK and B-cell chronic lymphocytic leukemia: This is because Btk has been reported to induce STAT3 activation and consequent IL-10 production in B cells [upon induction with Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A)] and leukemic CLL cells [40, 41].